X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-02 | CERT | Smith Patrick F | Pres, DRUG DEV SOLUTIONS | S - Sale | $16.85 | -14,427 | 50,091 | -22% | -$243,161 | ||||||
| D | 2024-04-01 | CERT | Traynor Richard M. | SVP, GC | S - Sale+OE | $18.00 | -3,000 | 173,524 | -2% | -$54,000 | |||||
2024-03-04 | CERT | Traynor Richard M. | SVP, GC | S - Sale | $18.28 | -3,000 | 162,368 | -2% | -$54,840 | ||||||
2024-02-20 | CERT | Smith Patrick F | Pres, DRUG DEV SOLUTIONS | S - Sale | $18.00 | -5,000 | 54,975 | -8% | -$90,000 | ||||||
2024-02-12 | CERT | Traynor Richard M. | SVP, GC | S - Sale | $18.00 | -6,000 | 165,368 | -4% | -$108,000 | ||||||
2023-12-26 | CERT | Traynor Richard M. | SVP, GC | S - Sale | $18.00 | -6,000 | 171,368 | -3% | -$108,000 | ||||||
2023-09-11 | CERT | Pedersen Leif E | Pres, CHIEF COMMERCAL OFF | S - Sale | $14.60 | -51,224 | 128,883 | -28% | -$747,870 | ||||||
| M | 2023-08-21 | CERT | Broshy Eran | Dir | P - Purchase | $15.81 | +5,000 | 14,360 | +53% | +$79,058 | |||||
2023-06-05 | CERT | Smith Patrick F | Pres, INTEGRATED DRUG DEV | S - Sale | $21.55 | -19,104 | 59,975 | -24% | -$411,691 | ||||||
2023-05-11 | CERT | Traynor Richard M. | SVP, GC | S - Sale | $20.82 | -5,000 | 177,368 | -3% | -$104,100 | ||||||
2023-04-14 | CERT | Traynor Richard M. | SVP, GC | S - Sale | $23.66 | -5,000 | 182,368 | -3% | -$118,300 | ||||||
2023-03-06 | CERT | Traynor Richard M. | SVP, GC | S - Sale | $21.45 | -10,000 | 184,564 | -5% | -$214,500 | ||||||
2023-02-02 | CERT | Traynor Richard M. | SVP, GC | S - Sale | $20.00 | -15,000 | 194,564 | -7% | -$300,000 | ||||||
2022-12-08 | CERT | Eqt Avatar Parent L.P. | 10% | S - Sale | $15.00 | -29,954,521 | 0 | -100% | -$449,317,815 | ||||||
2022-11-22 | CERT | Pedersen Leif E | Pres, SOFTWARE | S - Sale | $15.55 | -51,223 | 175,500 | -23% | -$796,518 | ||||||
| M | 2022-11-14 | CERT | Slaine Mason P | Dir | S - Sale | $15.57 | -250,000 | 660,322 | -27% | -$3,891,238 | |||||
2022-11-14 | CERT | Walsh Matthew M | Dir | S - Sale | $14.74 | -12,059 | 167,901 | -7% | -$177,750 | ||||||
2022-11-09 | CERT | Smith Patrick F | Pres, INTEGRATED DRUG DEV | S - Sale | $13.48 | -2,387 | 74,859 | -3% | -$32,177 | ||||||
2022-08-19 | CERT | McLean Stephen M. | Dir | P - Purchase | $16.32 | +20,000 | 42,000 | +91% | +$326,400 | ||||||
2022-08-17 | CERT | Schemick Michael Andrew | CFO | P - Purchase | $16.64 | +25,000 | 517,870 | +5% | +$416,000 | ||||||
2022-08-16 | CERT | Smith Patrick F | Pres, INTEGRATED DRUG DEV | S - Sale | $17.71 | -10,000 | 78,490 | -11% | -$177,100 | ||||||
2022-08-16 | CERT | Eqt Avatar Parent L.P. | 10% | S - Sale | $17.38 | -6,004,418 | 29,954,521 | -17% | -$104,356,785 | ||||||
2022-08-16 | CERT | Slaine Mason P | Dir | S - Sale | $17.38 | -182,475 | 910,322 | -17% | -$3,171,416 | ||||||
2022-06-08 | CERT | Smith Patrick F | Pres, INTEGRATED DRUG DEV | S - Sale | $19.16 | -10,000 | 88,490 | -10% | -$191,600 | ||||||
2022-06-02 | CERT | Slaine Mason P | Dir | S - Sale | $19.56 | -250,000 | 1,092,797 | -19% | -$4,890,000 | ||||||
2022-05-31 | CERT | Eqt Avatar Parent L.P. | 10% | S - Sale | $19.00 | -1,500,000 | 35,958,939 | -4% | -$28,500,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |